Overview
Anyone researching stretch mark creams will eventually run into palmitoyl tetrapeptide-7, a peptide ingredient formulated into topical skincare products. It is marketed as a cosmetic active rather than a systemic medication, and its labeled use centers on skin appearance.
Key Takeaways
- Marketed under the brand name "Stretch Marks cream" as a topical, cosmetic-style product.
- The label describes use for the appearance of stretch marks and scars and for supporting skin elasticity.
- Chemically, it is a synthetic peptide with the molecular formula C34H62N8O7.
- The label does not carry a boxed warning.
- One registered clinical trial reference appears in the available dataset.
What Palmitoyl Tetrapeptide-7 Is
Palmitoyl tetrapeptide-7 is a synthetic peptide compound, cataloged in PubChem under CID 10078408 with a molecular weight of about 695. The label lists its pharmacologic class category as a non-standardized food allergenic extract, a classification that reflects how the product is coded in regulatory databases rather than a therapeutic drug category. No mechanism of action is described in the available label data.
What Palmitoyl Tetrapeptide-7 Is Approved For
The labeled product, sold as Stretch Marks cream, is intended to address the appearance of stretch marks and scars and to support skin elasticity. The label describes topical use over the body, with attention to the abdomen, as part of a regular skincare routine. No boxed warning is present on this label.
What The Evidence Shows
The available dataset lists one registered clinical trial tied to this compound. That trial, a completed Phase 4 study, assessed facial skin quality, hydration, and skin barrier function across three Hydrafacial treatments in adults of all skin types.